Dr. Yvonne Saenger: Crushing Cancer’s Defenses
For about a decade, large clinical trials of cancer vaccine candidates have turned out mostly disappointing. But now a handful of new therapies are showing signs that the cancer vaccine effort could be on the brink of big breakthroughs. However, few melanoma vaccines have lived up to expectations, says Dr. Yvonne Saenger, a melanoma specialist at Mount Sinai School of Medicine in New York City. The drug MAGE-A3 may or may not be different, she says. She is waiting to see the Phase III results before weighing in. Learn more

Mount Sinai Researchers Discover How Melanoma May Spread to the Brain
Apr 30, 2025 View All Press Releases
Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases
Mount Sinai Leads Phase 3 Trial in Myelofibrosis Treatment
Mar 19, 2025 View All Press Releases
Mount Sinai Researchers Discover Why Some Colon Cancers Resist Treatment
Feb 12, 2025 View All Press Releases
Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study
Jan 09, 2025 View All Press Releases
Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy
Jan 06, 2025 View All Press Releases
New AI Tool by Mount Sinai Researchers Could Reshape Prostate Cancer Care
Sep 23, 2024 View All Press Releases